Trial Profile
Phase III Trial Exploring the Combination of Bevacizumab and Lomustine in Patients With First Recurrence of a Glioblastoma
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Lomustine
- Indications Glioblastoma
- Focus Therapeutic Use
- 01 Apr 2021 discrepancy in phase, as per incoming result3553747, phase II/III is mentioned, while as per NCT and Eudra it is phase III.Retained as per NCT and Eudra for now.Pls update further.
- 15 Jun 2018 The study has been completed in Italy.
- 02 Jun 2018 The study has been completed in Germany (End date: 2018-02-10).